Table 1.

Ratio of HRMCs in S Phase From Different Groups

	S phase (mean ± SD)	*p
NC%	68.88 ± 0.70	–
MiR-155%	68.10 ± 1.57	> 0.05 (versus NC%)
CXCL13 + NC%	76.09 ± 1.44	< 0.05 (versus NC%)
CXCL13 + MiR-155%	62.03 ± 0.30	< 0.05 (versus CXCL13 + NC%)
CXCL13 + siRNA%	65.46 ± 0.05	< 0.05 (versus CXCL13 + NC%)

Statistical analyses were performed by ANOVA followed by Dunnett’s test. *p < 0.05 was considered significant